Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Research Institute of Chemical Industry (ZRICI) is a leading Chinese research and development institution and a core subsidiary of Sinochem Holdings. Founded in 1950 and headquartered in Hangzhou, the institute specializes in fluorine chemistry, agrochemicals, and pharmaceutical intermediates. ZRICI operates as a comprehensive service provider, offering contract research (CRO) and contract development and manufacturing (CDMO) services to the global life sciences industry. The institute is home to several national-level research centers, focusing on the synthesis of complex small molecules and the development of innovative crop protection products. With advanced manufacturing capabilities and GLP-certified laboratories, ZRICI supports partners from early-stage process development through to commercial-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Research Institute of Chemical Industry.